CHANG; Hui-Wen

Patent Applications and Registrations

Patent applications and USPTO patent grants for CHANG; Hui-Wen.The latest application filed is for "immunogenic composition for porcine epidemic diarrhea virus".

Company Profile

5.9.13

CHANG; Hui-Wen - Taipei City TW
Chang; Hui-Wen - Taipei TW
Chang; Hui-Wen - Hsinchu TW
CHANG; HUI WEN - Taoyuan TW
Chang; Hui-wen - Utrecht N/A NL
CHANG; Hui-Wen - Hsinchu City TW
Chang; Hui Wen - Tucheng TW
Chang, Hui Wen - Tucheng City TW

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Immunogenic Composition For Porcine Epidemic Diarrhea Virus App 20220111032 - WU; Tzong-Yuan ; et al.	2022-04-14
Baculovirus and composition for detection and preventing of porcine epidemic diarrhea virus infection Grant 11,123,424 - Chao , et al. September 21, 2	2021-09-21
Baculovirus And Composition For Detection And Preventing Of Porcine Epidemic Diarrhea Virus Infection App 20190388535 - CHAO; Yu-Chan ; et al.	2019-12-26
Thermally conductive resin and thermal interface material comprising the same Grant 10,329,468 - Liu , et al.	2019-06-25
Chip-type Passive Component App 20190066904 - CHANG; HUI WEN	2019-02-28
Epoxy resin compositions and thermal interface materials comprising the same Grant 10,059,866 - Liu , et al. August 28, 2	2018-08-28
Means and methods for distinguishing FECV and FIPV Grant 9,796,996 - Rottier , et al. October 24, 2	2017-10-24
Thermally Conductive Resin And Thermal Interface Material Comprising The Same App 20170158934 - LIU; Yen-Chun ; et al.	2017-06-08
Epoxy Resin Compositions And Thermal Interface Materials Comprising The Same App 20170158932 - LIU; Yen-Chun ; et al.	2017-06-08
Polyamide-imides, graphite films and preparation for the graphite film Grant 9,371,233 - Lin , et al. June 21, 2	2016-06-21
Polyamide-imides, Graphite Films And Preparation For The Graphite Film App 20150166347 - LIN; Chen-Lung ; et al.	2015-06-18
Method of identifying a candidate compound which may inhibit .alpha.9-nAchR overexpression or estrogen receptor-dependent transcription in nicotine-derived-compound-induced breast cancer cells Grant 8,980,571 - Lee , et al. March 17, 2	2015-03-17
Means And Methods For Distinguishing Fecv And Fipv App 20130071833 - Rottier; Petrus Josephus Marie ; et al.	2013-03-21
METHOD OF IDENTIFYING A CANDIDATE COMPOUND WHICH MAY INHIBIT a9-nAchR OVEREXPRESSION OR ESTROGEN RECEPTOR-DEPENDENT TRANSCRIPTION IN NICOTINE-DERIVED-COMPOUND-INDUCED BREAST CANCER CELLS App 20120270799 - Lee; Chia-Hwa ; et al.	2012-10-25
Use Of Tea Polyphenols For Treating And/or Preventing Nicotine Or Nicotine-derived Compounds Or Estrogen Induced Breast Cancer App 20120208872 - Tu; Shih-Hsin ; et al.	2012-08-16
Tea Polyphenols Products For Ceasing Smoking And Treating And/or Preventing Nicotine Or Nicotine-derived Compounds Or Estrogen Induced Breast Cancer App 20120208873 - Tu; Shih-Hsin ; et al.	2012-08-16
Method and system for target lifetime Grant 7,282,122 - Chang , et al. October 16, 2	2007-10-16
Method and system for target lifetime App 20050211549 - Chang, Hui Wen ; et al.	2005-09-29

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.